392 related articles for article (PubMed ID: 27686254)
21. Generating Protein-Linked and Protein-Free Mono-, Oligo-, and Poly(ADP-Ribose) In Vitro.
Lin KY; Huang D; Kraus WL
Methods Mol Biol; 2018; 1813():91-108. PubMed ID: 30097863
[TBL] [Abstract][Full Text] [Related]
22. Differential and Concordant Roles for Poly(ADP-Ribose) Polymerase 1 and Poly(ADP-Ribose) in Regulating WRN and RECQL5 Activities.
Khadka P; Hsu JK; Veith S; Tadokoro T; Shamanna RA; Mangerich A; Croteau DL; Bohr VA
Mol Cell Biol; 2015 Dec; 35(23):3974-89. PubMed ID: 26391948
[TBL] [Abstract][Full Text] [Related]
23. Poly(ADP-ribose) polymerase-1 affects vasopressin-mediated AQP2 expression in collecting duct cells of the kidney.
Jang HJ; Park E; Jung HJ; Kwon TH
Am J Physiol Renal Physiol; 2024 Jan; 326(1):F69-F85. PubMed ID: 37855039
[TBL] [Abstract][Full Text] [Related]
24. PARP1 inhibition alleviates injury in ARH3-deficient mice and human cells.
Mashimo M; Bu X; Aoyama K; Kato J; Ishiwata-Endo H; Stevens LA; Kasamatsu A; Wolfe LA; Toro C; Adams D; Markello T; Gahl WA; Moss J
JCI Insight; 2019 Feb; 4(4):. PubMed ID: 30830864
[TBL] [Abstract][Full Text] [Related]
25. Poly(ADP-ribose) Polymerase 1 Modulates Interaction of the Nucleotide Excision Repair Factor XPC-RAD23B with DNA via Poly(ADP-ribosyl)ation.
Maltseva EA; Rechkunova NI; Sukhanova MV; Lavrik OI
J Biol Chem; 2015 Sep; 290(36):21811-20. PubMed ID: 26170451
[TBL] [Abstract][Full Text] [Related]
26. PARP-1 Controls the Adipogenic Transcriptional Program by PARylating C/EBPβ and Modulating Its Transcriptional Activity.
Luo X; Ryu KW; Kim DS; Nandu T; Medina CJ; Gupte R; Gibson BA; Soccio RE; Yu Y; Gupta RK; Kraus WL
Mol Cell; 2017 Jan; 65(2):260-271. PubMed ID: 28107648
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of PARP1 Increases IRF-dependent Gene Transcription in Jurkat Cells.
Wang C; Du M; Huang D; Huang K; Huang K
Curr Med Sci; 2019 Jun; 39(3):356-362. PubMed ID: 31209803
[TBL] [Abstract][Full Text] [Related]
28. Epstein-Barr Virus Oncoprotein LMP1 Mediates Epigenetic Changes in Host Gene Expression through PARP1.
Martin KA; Lupey LN; Tempera I
J Virol; 2016 Oct; 90(19):8520-30. PubMed ID: 27440880
[TBL] [Abstract][Full Text] [Related]
29. The Enigmatic Function of PARP1: From PARylation Activity to PAR Readers.
Kamaletdinova T; Fanaei-Kahrani Z; Wang ZQ
Cells; 2019 Dec; 8(12):. PubMed ID: 31842403
[TBL] [Abstract][Full Text] [Related]
30. Regulation of poly(ADP-Ribose) polymerase 1 functions by post-translational modifications.
Piao L; Fujioka K; Nakakido M; Hamamoto R
Front Biosci (Landmark Ed); 2018 Jan; 23(1):13-26. PubMed ID: 28930534
[TBL] [Abstract][Full Text] [Related]
31. [Poly(ADP-Ribose) Polymerases 1 and 2: Classical Functions and Interaction with New Histone Poly(ADP-Ribosyl)ation Factor HPF1].
Kurgina TA; Lavrik OI
Mol Biol (Mosk); 2023; 57(2):254-268. PubMed ID: 37000654
[TBL] [Abstract][Full Text] [Related]
32. Nuclear PTEN interferes with binding of Ku70 at double-strand breaks through post-translational poly(ADP-ribosyl)ation.
Guan J; Zhao Q; Mao W
Biochim Biophys Acta; 2016 Dec; 1863(12):3106-3115. PubMed ID: 27741411
[TBL] [Abstract][Full Text] [Related]
33. New perspectives on the plant PARP family: Arabidopsis PARP3 is inactive, and PARP1 exhibits predominant poly (ADP-ribose) polymerase activity in response to DNA damage.
Gu Z; Pan W; Chen W; Lian Q; Wu Q; Lv Z; Cheng X; Ge X
BMC Plant Biol; 2019 Aug; 19(1):364. PubMed ID: 31426748
[TBL] [Abstract][Full Text] [Related]
34. The histone methyltransferase SMYD2 methylates PARP1 and promotes poly(ADP-ribosyl)ation activity in cancer cells.
Piao L; Kang D; Suzuki T; Masuda A; Dohmae N; Nakamura Y; Hamamoto R
Neoplasia; 2014 Mar; 16(3):257-64, 264.e2. PubMed ID: 24726141
[TBL] [Abstract][Full Text] [Related]
35. SIRT3 inhibits cardiac hypertrophy by regulating PARP-1 activity.
Feng X; Wang Y; Chen W; Xu S; Li L; Geng Y; Shen A; Gao H; Zhang L; Liu S
Aging (Albany NY); 2020 Mar; 12(5):4178-4192. PubMed ID: 32139662
[TBL] [Abstract][Full Text] [Related]
36. Poly(ADP-ribose): PARadigms and PARadoxes.
Bürkle A; Virág L
Mol Aspects Med; 2013 Dec; 34(6):1046-65. PubMed ID: 23290998
[TBL] [Abstract][Full Text] [Related]
37. CD38 promotes angiotensin II-induced cardiac hypertrophy.
Guan XH; Hong X; Zhao N; Liu XH; Xiao YF; Chen TT; Deng LB; Wang XL; Wang JB; Ji GJ; Fu M; Deng KY; Xin HB
J Cell Mol Med; 2017 Aug; 21(8):1492-1502. PubMed ID: 28296029
[TBL] [Abstract][Full Text] [Related]
38. Molecular mechanism of poly(ADP-ribosyl)ation by PARP1 and identification of lysine residues as ADP-ribose acceptor sites.
Altmeyer M; Messner S; Hassa PO; Fey M; Hottiger MO
Nucleic Acids Res; 2009 Jun; 37(11):3723-38. PubMed ID: 19372272
[TBL] [Abstract][Full Text] [Related]
39. The C-terminal domain of p53 orchestrates the interplay between non-covalent and covalent poly(ADP-ribosyl)ation of p53 by PARP1.
Fischbach A; Krüger A; Hampp S; Assmann G; Rank L; Hufnagel M; Stöckl MT; Fischer JMF; Veith S; Rossatti P; Ganz M; Ferrando-May E; Hartwig A; Hauser K; Wiesmüller L; Bürkle A; Mangerich A
Nucleic Acids Res; 2018 Jan; 46(2):804-822. PubMed ID: 29216372
[TBL] [Abstract][Full Text] [Related]
40. Repression of phosphoenolpyruvate carboxykinase gene activity by insulin is blocked by 3-aminobenzamide but not by PD128763, a selective inhibitor of poly(ADP-ribose) polymerase.
Yau L; Elliot T; Lalonde C; Zahradka P
Eur J Biochem; 1998 Apr; 253(1):91-100. PubMed ID: 9578465
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]